These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 30655173)

  • 1. Development of an auxotrophic, live-attenuated Brucella suis vaccine strain capable of expressing multimeric GnRH.
    Smith GP; Jain-Gupta N; Alqublan H; Dorneles EMS; Boyle SM; Sriranganathan N
    Vaccine; 2019 Feb; 37(7):910-914. PubMed ID: 30655173
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Over-expression of homologous antigens in a leucine auxotroph of Brucella abortus strain RB51 protects mice against a virulent B. suis challenge.
    Rajasekaran P; Surendran N; Seleem MN; Sriranganathan N; Schurig GG; Boyle SM
    Vaccine; 2011 Apr; 29(17):3106-10. PubMed ID: 21376799
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Development of attenuated live vaccine candidates against swine brucellosis in a non-zoonotic B. suis biovar 2 background.
    Aragón-Aranda B; de Miguel MJ; Lázaro-Antón L; Salvador-Bescós M; Zúñiga-Ripa A; Moriyón I; Iriarte M; Muñoz PM; Conde-Álvarez R
    Vet Res; 2020 Jul; 51(1):92. PubMed ID: 32703299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Brucella suis strain 2 vaccine is safe and protective against heterologous Brucella spp. infections.
    Zhu L; Feng Y; Zhang G; Jiang H; Zhang Z; Wang N; Ding J; Suo X
    Vaccine; 2016 Jan; 34(3):395-400. PubMed ID: 26626213
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Delta-pgm, a new live-attenuated vaccine against Brucella suis.
    Czibener C; Del Giudice MG; Spera JM; Fulgenzi FR; Ugalde JE
    Vaccine; 2016 Mar; 34(13):1524-1530. PubMed ID: 26899373
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Duplex PCR for differentiation of the vaccine strain Brucella suis S2 and B. suis biovar 1 from other strains of Brucella spp.
    Nan W; Tan P; Wang Y; Xu Z; Mao K; Peng D; Chen Y
    Vet J; 2014 Sep; 201(3):427-8. PubMed ID: 25011712
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development and characterization of mouse models of infection with aerosolized Brucella melitensis and Brucella suis.
    Smither SJ; Perkins SD; Davies C; Stagg AJ; Nelson M; Atkins HS
    Clin Vaccine Immunol; 2009 May; 16(5):779-83. PubMed ID: 19321692
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rough Brucella neotomae provides protection against Brucella suis challenge in mice.
    Jain-Gupta N; Waldrop SG; Tenpenny NM; Witonsky SG; Boyle SM; Sriranganathan N
    Vet Microbiol; 2019 Dec; 239():108447. PubMed ID: 31767087
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Development and evaluation of in murine model, of an improved live-vaccine candidate against brucellosis from to Brucella melitensis vjbR deletion mutant.
    Li Z; Wang S; Zhang H; Xi L; Zhang J; Zhang X; Zhou Q; Yi J; Li M; Zhang W; Zhang J
    Microb Pathog; 2018 Nov; 124():250-257. PubMed ID: 30149131
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Venezuelan field trials of vaccines against brucellosis in swine.
    Lord VR; Cherwonogrodzky JW; Schurig GG; Lord RD; Marcano MJ; Meléndez GE
    Am J Vet Res; 1998 May; 59(5):546-51. PubMed ID: 9582954
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Brucella melitensis M5-90 wboA deletion strain is attenuated and enhances vaccine efficacy.
    Li ZQ; Shi JX; Fu WD; Zhang Y; Zhang J; Wang Z; Li TS; Chen CF; Guo F; Zhang H
    Mol Immunol; 2015 Aug; 66(2):276-83. PubMed ID: 25899866
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immune responses and protection induced by Brucella suis S2 bacterial ghosts in mice.
    Liu J; Li Y; Sun Y; Ji X; Zhu L; Guo X; Zhou W; Zhou B; Liu S; Zhang R; Feng S
    Vet Immunol Immunopathol; 2015 Aug; 166(3-4):138-44. PubMed ID: 26022514
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of serology and bacterial culture to determine prevalence of Brucella spp. In feral Swine (sus scrofa) in proximity to a beef cattle herd positive for Brucella suis and Brucella abortus.
    Musser JM; Schwartz AL; Srinath I; Waldrup KA
    J Wildl Dis; 2013 Apr; 49(2):215-20. PubMed ID: 23568896
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of Brucella suis from feral swine in selected states in the USA.
    Pedersen K; Quance CR; Robbe-Austerman S; Piaggio AJ; Bevins SN; Goldstein SM; Gaston WD; DeLiberto TJ
    J Wildl Dis; 2014 Apr; 50(2):171-9. PubMed ID: 24484477
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioluminescence Imaging of Colonization and Clearance Dynamics of Brucella Suis Vaccine Strain S2 in Mice and Guinea Pigs.
    Wang X; Li Z; Li B; Chi H; Li J; Fan H; Yao R; Li Q; Dong X; Chen M; Qu H; Wang Y; Gao W; Wang Y; Sun Y; Sun R; Qian J; Xia Z
    Mol Imaging Biol; 2016 Aug; 18(4):519-26. PubMed ID: 26846129
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Research progress in live attenuated Brucella vaccine development.
    Wang Z; Wu Q
    Curr Pharm Biotechnol; 2013; 14(10):887-96. PubMed ID: 24372253
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with a ΔnorD ΔznuA Brucella abortus mutant confers potent protection against virulent challenge.
    Yang X; Clapp B; Thornburg T; Hoffman C; Pascual DW
    Vaccine; 2016 Oct; 34(44):5290-5297. PubMed ID: 27639282
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunization of BALB/c mice with a combination of four recombinant Brucella abortus proteins, AspC, Dps, InpB and Ndk, confers a marked protection against a virulent strain of Brucella abortus.
    Hop HT; Arayan LT; Huy TXN; Reyes AWB; Min W; Lee HJ; Park SJ; Chang HH; Kim S
    Vaccine; 2018 May; 36(21):3027-3033. PubMed ID: 29678458
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.